Search
for
Sort by
Research 211–240 of 1000+
- Side gland of Suncus murinus as a new model of sebaceous gland: 5?-reductase, androgen receptor, and nuclear androgen content in male and female animals
- Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Macular Abnormalities Associated With 5α-Reductase Inhibitor
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- Bioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia
- Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients
- Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
- Steroid 5α-reductase inhibition by polymethoxyflavones
- Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention
- Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase
- Long-Term Experience With 5-alpha-Reductase Inhibitors.
- Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair loss
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2
- Mechanistic insights into 5-aminolevulinic acid photodynamic therapy for acne vulgaris: targeting lipogenesis via the OLR1-Wnt/β-catenin pathway
- Pathogenetic justification of the use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia.
- Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
- The connection of 5-alpha reductase inhibitors to the development of depression
- Extract of <i>Plumbago zeylanica</i> enhances the growth of hair follicle dermal papilla cells with down‐regulation of 5α‐reductase type II
- Possible role of 5-alpha reductase inhibitors in non-invasive bladder urothelial neoplasm: multicentre study
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Differential distribution of the epigenetic marker 5‐hydroxymethylcytosine occurs in hair follicle stem cells during bulge activation
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis